Recruiting

Observational Study

Sponsor:

University of Alabama at Birmingham

Code:

NCT06911723

Conditions

Schizophrenia Disorders

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Interventions

Brief Activities

Study Details

Brief summary:

This is a study investigating how brief online activities can influence mood and attitudes.

Conditions

Schizophrenia Disorders

Study ID

NCT06911723

Start date

Aug 20, 2025

Status verified date

Aug, 2026

Completion date

Dec, 2028

Anticipated

Primary completion date

Oct, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Inclusion Criteria:

  • aged 18-65
  • schizophrenia group - have a psychotic disorder diagnosis
  • healthy control group - Do not have a current DSM-5 diagnosis via the SCID-5

Study Design

Enrollment

200 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Emotion Coping Activities

experimental: Belief Modifying Activities

Interventions

Brief Activities

The activities will be completed online.

Primary outcome measure

  • Patient Health Questionnaire - PHQ-9 [ Time Frame: Assessed at baseline (day 1) and after study completion, an average of a week ]
  • Generalized Anxiety Disorder 7-item - GAD-7 [ Time Frame: Assessed at baseline (day 1) and after study completion, an average of a week ]
  • The Motivation and Pleasure Scale-Self-Report - MAP-SR [ Time Frame: Assessed at baseline (day 1) and after study completion, an average of a week ]

Central Contacts and Locations

Central contacts

Lauren Luther, PhD

(205) 934-3850cas-treatlab@uab.edu

Locations

University of Alabama at Birmingham

Recruiting

Birmingham, Alabama, United States, 35223-1517

Contacts

Lauren Luther, PhD

205-530-1117cas-treatlab@uab.edu

More Information

Sponsor

University of Alabama at Birmingham

Last update posted

Aug 31, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Alabama at Birmingham on 2026-08-31.